ERS posts FY 2020 CR of 91.9% as pivot to specialty lines continues
Aquiline-backed ERS has reported a combined ratio of 91.9 percent for 2020, an improvement of 7.8 points year on year.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below